8.93
price down icon1.54%   -0.14
after-market Dopo l'orario di chiusura: 9.00 0.07 +0.78%
loading

Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie

pulisher
06:35 AM

Aurinia Pharmaceuticals Inc. Stock Analysis and ForecastConsistent triple returns - PrintWeekIndia

06:35 AM
pulisher
06:31 AM

What analysts say about Aurinia Pharmaceuticals Inc. stockRapid growth opportunities - Autocar Professional

06:31 AM
pulisher
Jul 24, 2025

Is Aurinia Pharmaceuticals Inc. a good long term investmentTremendous financial leverage - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Will Aurinia Pharmaceuticals Inc. stock split in the near futureHigh-octane financial growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Aurinia Pharmaceuticals Inc. stock priceUnmatched profit growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

When is the best time to buy Aurinia Pharmaceuticals Inc. stockSuperior profit margins - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - BioSpace

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals: LUPKYNIS Growth and AUR200 Pipeline Fuel Long-Term Value - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Yahoo.co

Jul 22, 2025
pulisher
Jul 20, 2025

(AUPH) Technical Data - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Delivers Shareholders Favorable 52% Return Over 1 Year, Surging 5.5% in the Last Week Alone - 富途牛牛

Jul 18, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Aurinia Pharmaceuticals Inc. stock price move sharplyDaily Breakout Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Aurinia Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Aurinia Pharmaceuticals Inc. stock attracts strong analyst attentionReal Trader Insights - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

How did AUPH's Q3 2024 earnings surprise impact short-term traders? - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Trading (AUPH) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 08, 2025

Wheat from chaff in BAFF: APRIL’s advent for Aurinia? - BioWorld MedTech

Jul 08, 2025
pulisher
Jul 07, 2025

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 06, 2025

Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results - MSN

Jul 06, 2025
pulisher
Jul 02, 2025

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

Implied Volatility Surging For Aurinia Pharmaceuticals Stock Options - Barchart.com

Jul 02, 2025
pulisher
Jul 01, 2025

Leerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH) - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Aurinia’s aritinercept shows promising results in phase 1 study - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - New Castle News

Jun 30, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):